Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Blossomhill Therapeutics IncfiledCriticalBlossomhill Therapeutics Inc
Publication of AR125934A1publicationCriticalpatent/AR125934A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems
(AREA)
Abstract
Un compuesto de la fórmula (1), o una sal farmacéuticamente aceptable de este. Una composición farmacéutica que comprende al menos un compuesto de acuerdo con una cualquiera de las reivindicaciones de 1 a 53, o una sal farmacéuticamente aceptable de este, y opcionalmente uno o más excipientes farmacéuticamente aceptables.A compound of formula (1), or a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprising at least one compound according to any one of claims 1 to 53, or a pharmaceutically acceptable salt thereof, and optionally one or more pharmaceutically acceptable excipients.
ARP220101353A2020-05-112022-05-20
MACROCYCLIC COMPOUNDS TO TREAT DISEASES
AR125934A1
(en)
COMPOUND 5 - OXO - REPLACED PIRROLIDIN, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND ITS USE TO PREPARE A MEDICINAL PRODUCT FOR THE TREATMENT OF GLAUCOMA.